{"id":"W1522421496","doi":"10.1016/j.ohc.2006.05.009","title":"10.1016/j.ohc.2006.05.009","year":2000,"lang":"en","type":"review","venue":"Time to knit","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":299,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Ranibizumab; Medicine; Dosing; Visual acuity; Clinical trial; Ophthalmology; Adverse effect; Stroke (engine); Regimen; Bevacizumab; Internal medicine; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00005397056,0.00049186,0.001615263,0.0001903026,0.00005132849,0.00003213664,0.0001757287,0.0002183927,0.9930588],"category_scores_gemma":[0.00003389183,0.0003516393,0.0007724978,0.0002936336,0.00002970256,0.00002873287,0.00005278732,0.0002163162,0.9972183],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001495103,"about_ca_system_score_gemma":0.0002483314,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001715475,"about_ca_topic_score_gemma":1.914165e-8,"domain_scores_codex":[0.9983394,0.00006219725,0.0004301727,0.000471325,0.0003195667,0.0003773014],"domain_scores_gemma":[0.9986617,0.00005406995,0.0001161483,0.0006188836,0.00004377931,0.0005054206],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005678963,0.0001644154,1.05328e-8,0.00254843,0.0002573435,0.0002615174,6.102742e-7,8.405814e-8,3.74907e-9,1.398468e-7,0.2081932,0.7885175],"study_design_scores_gemma":[0.0003590546,0.000499489,0.000001396327,0.009098921,0.003534147,0.0002010609,9.039855e-8,9.390854e-7,4.272469e-8,0.000001074096,0.9860166,0.0002871969],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"other","genre_scores_codex":[4.415501e-8,0.5016271,1.751562e-8,0.00001991408,0.000001463596,0.0006394157,0.0001189264,0.00005498602,0.4975381],"genre_scores_gemma":[4.116847e-9,0.3536924,0.00001848846,0.00001984701,0.0002062255,0.00005509386,0.0005273311,0.00006684784,0.6454137],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.7882302,"threshold_uncertainty_score":0.9998935,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02071203103106387,"score_gpt":0.2757241986666178,"score_spread":0.2550121676355539,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}